A team of scientists has discovered a vaccine taken twice a year that may be a substitute for statins, or "statins," and could make a big difference in the lives of millions of people with high cholesterol.
The study, conducted by scientists at the British company Medicines, which is working on the development of the drug, concluded that the injection led to the reduction of bad cholesterol levels in the participants by half without leaving any obvious side effects. The study involved 1,600 people and took 18 months. The study was led by Kozyk Rai, a professor of public health and a cardiologist at Imperial College in London.
According to doctors, patients will be able to replace daily statins with an annual injection that also helps reduce the risk of a heart attack or stroke.